The Multifaceted Nature of Streptococcal Antigen I/II Proteins in Colonization and Disease Pathogenesis by Manzer, Haider S et al.
                          Manzer, H. S., Nobbs, A. H., & Doran, K. S. (2020). The Multifaceted
Nature of Streptococcal Antigen I/II Proteins in Colonization and
Disease Pathogenesis. Frontiers in Microbiology, 11, [602305].
https://doi.org/10.3389/fmicb.2020.602305
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.3389/fmicb.2020.602305
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Frontiers Media at
https://doi.org/10.3389/fmicb.2020.602305 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
fmicb-11-602305 November 19, 2020 Time: 16:40 # 1
REVIEW


















This article was submitted to
Infectious Diseases,
a section of the journal
Frontiers in Microbiology
Received: 03 September 2020
Accepted: 29 October 2020
Published: 25 November 2020
Citation:
Manzer HS, Nobbs AH and
Doran KS (2020) The Multifaceted
Nature of Streptococcal Antigen I/II




The Multifaceted Nature of
Streptococcal Antigen I/II Proteins in
Colonization and Disease
Pathogenesis
Haider S. Manzer1, Angela H. Nobbs2 and Kelly S. Doran1*
1 Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO,
United States, 2 Bristol Dental School, University of Bristol, Bristol, United Kingdom
Streptococci are Gram-positive bacteria that belong to the natural microbiota of humans
and animals. Certain streptococcal species are known as opportunistic pathogens with
the potential to cause severe invasive disease. Antigen I/II (AgI/II) family proteins are
sortase anchored cell surface adhesins that are nearly ubiquitous across streptococci
and contribute to many streptococcal diseases, including dental caries, respiratory tract
infections, and meningitis. They appear to be multifunctional adhesins with affinities to
various host substrata, acting to mediate attachment to host surfaces and stimulate
immune responses from the colonized host. Here we will review the literature including
recent work that has demonstrated the multifaceted nature of AgI/II family proteins,
focusing on their overlapping and distinct functions and their important contribution to
streptococcal colonization and disease.
Keywords: antigen I/II, Streptococcus, adhesin, dental caries, respiratory infection, vaginal colonization,
meningitis, biofilms
INTRODUCTION
The genus Streptococcus is a heterogeneous group of Gram-positive bacteria that can be part
of the natural microbiota. Various streptococci are commonly isolated from the oral cavity,
intestines, or female reproductive tracts in healthy humans. These colonizing streptococci are
often commensal organisms that persist without causing disease. In some cases, colonization
by commensal streptococci can actually benefit the host through mechanisms such as niche
competition or direct inhibition of more pathogenic organisms (Abranches et al., 2018; Nobbs and
Kreth, 2019); however, there are also many streptococcal species that are opportunistic pathogens
with the potential to cause severe invasive disease. Within the viridans group of streptococci, a
heterogeneous group consisting of typically commensal α-hemolytic species, exists Streptococcus
mutans. S. mutans is a major agent of dental caries (tooth decay) (Lehner et al., 1975) and infective
endocarditis (Hoen et al., 2002). Streptococcus pyogenes (Group A Streptococcus, GAS) is a major
cause of skin and soft tissue infections, as well as respiratory infections (Steer et al., 2012). Similarly,
Streptococcus agalactiae (Group B Streptococcus, GBS) is known to colonize the female reproductive
tract and is a leading cause of neonatal sepsis, pneumonia, and meningitis (Edmond et al., 2012).
Understanding the shared mechanisms by which these diverse species colonize and cause disease
is the first step toward treatment and prevention. One example of a shared virulence factor among
these species is the family of multifunctional streptococcal surface anchored adhesins known as
antigen I/II (AgI/II) proteins.
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Mike Russell et al. and Roy Russell et al. identified the cell wall
antigens I and II in Streptococcus mutans nearly simultaneously
over 40 years ago (Russell and Lehner, 1978; Russell, 1979; Russell
et al., 1980). Soon after, it was shown that antigen II was actually
a breakdown product of antigen I (Kelly et al., 1989), giving rise
to their new classification as antigen I/II proteins. These AgI/II
proteins are widely distributed not only among various serotypes
within S. mutans (Russell and Lehner, 1978; Russell et al.,
1980; Ma et al., 1991), but orthologous proteins sharing similar
structure and functions also exist within a number of other
streptococcal species (Kelly et al., 1989; Jenkinson and Demuth,
1997; Brady et al., 2010). Due in part to the initial discovery of
AgI/II proteins within S. mutans, their contribution to dental
caries has been a major focus of AgI/II related research; however,
more recent studies have investigated AgI/II proteins in other
species and biological niches as well. The multifunctional nature
of these adhesins in multiple niches may directly contribute to the
transition toward pathogenesis as the same protein that promotes
colonization of a commensal or beneficial organism in one niche
may also allow persistence after that organism gains access to
new and potentially more susceptible host tissues. Furthermore,
discrete locations of various binding sites on AgI/II proteins for
interaction with different microorganisms and host molecules
ensures maximum protein functionality, which could be a key
mechanism for generating diversity in the development of
microbial communities. In addition to the cariogenic properties
of AgI/II proteins, these studies have revealed diverse functions
ranging from adherence to immune modulation, which in turn
contribute to streptococcal colonization and disease.
NOMENCLATURE
Proteins belonging to the AgI/II family that have been identified
to date are known by various names, many of which are shown in
Table 1. The majority of these were independently studied and
named by different groups prior to the widespread availability
of sequencing technologies that eventually revealed that these
were, in fact, the same proteins. For example, the single S. mutans
AgI/II protein is known by at least seven different names. In
some cases, the different names represent different proteins
coded by unique genes within the same species; BspA-D in GBS,
SspA/B in S. gordonii, and PAaA/B in S. criceti are examples of
this. Standardization of the nomenclature in future publications
would significantly clarify which proteins are being discussed.
A few groups have used the “AgI/II” designation for antigen I/II
proteins regardless of the species to which the protein belongs
(Sciotti et al., 1997; Chuzeville et al., 2017; Auger et al., 2019).
PREVALENCE AND CONSERVATION
AgI/II proteins are nearly ubiquitous within streptococci. In
order to examine the relatedness of AgI/II proteins across species,
representative genes from those listed in Table 1 were aligned,
and their phylogenetic relationships are shown in Figure 1A.
Orthologous genes, many of which have yet to be further
TABLE 1 | AgI/II family protein names by species.
Species Protein name(s) Reference(s)
S. mutans SpaP/P1/PAc/Sr/
MSL-1/AgB/IF
Russell and Lehner, 1978; Russell et al.,
1980; Kelly et al., 1989; Demuth et al.,
1990b; Ogier et al., 1990; Bleiweis et al.,
1992; Jenkinson and Demuth, 1997
S. gordonii SspA/SspB Demuth et al., 1996; Brooks et al., 1997;
Jenkinson and Demuth, 1997
S. agalactiae BspA-D/PAc/SSP-5 Tettelin et al., 2005; Rego et al., 2016
S. pyogenes Spy1352/AspA Zhang et al., 2006
S. sobrinus SpaA/PAg LaPolla et al., 1991
S. sanguinis SSP-5/PAc Demuth et al., 1988, 1990a,b
S. intermedius Pas Petersen et al., 2001, 2002; Tamura et al.,
2001
S. criceti PAaA/PAaB Tamura et al., 2001, 2004
S. downei PAh Tamura et al., 2008
S. suis SSP-5/AgI/II Chuzeville et al., 2017; Auger et al., 2019
The most common names used to refer to AgI/II proteins from different
Streptococcus species are listed.
characterized and may not be expressed at the protein level, were
also identified in S. rattus, S. oralis, S. mitis, S. anginosus, S.
constellatus, S. vestibularis, and S. parasanguinis via amplification
from S. mutans SpaP based PCR probes (Ma et al., 1991). Another
potential AgI/II protein was recently identified in S. salivarius
as well, though it also remains to be characterized (Chaffanel
et al., 2018). As AgI/II genes are so widely distributed among
streptococci, it is likely that other species that were not listed here
also contain AgI/II orthologs that have yet to be identified. For
example, while there was previously no evidence for an AgI/II
gene within S. pneumoniae (Brady et al., 2010), a BLASTP search
for homologs of the GAS AgI/II gene AspA within S. pneumoniae
strains revealed a homologous protein in a newly sequenced
strain (NCBI RefSeq: WP_160544519.1). This protein has a
similar primary structure with 69% pairwise identity to AspA,
with 83% coverage, which is comparable to the variation that
exists between AgI/II genes from different species. While this was
the only S. pneumoniae strain we found containing an AgI/II
homolog, its presence nonetheless highlights the widespread
distribution of AgI/II proteins and their potential to provide
pathogens with a selective advantage in certain niches.
Previous studies comparing sequences across AgI/II genes
from multiple species have revealed domain-based variation in
conservation (Ma et al., 1991; Brady et al., 2010; Deng et al., 2019).
This is shown to be especially true when protein sequences from a
larger number of species are compared (Figure 1B). Comparisons
of AgI/II genes from multiple strains within one species, however,
reveal high levels of sequence conservation (Brady et al., 1991;
Ma et al., 1991; Do et al., 2010; Chuzeville et al., 2015; Rego
et al., 2016). For example, a study comparing 37 S. mutans SpaP
genes observed non-synonymous polymorphisms in only 4% of
sites (Do et al., 2010). This indicates both diversity within the
AgI/II family of proteins, as well as specificity, where the AgI/II
proteins within each species may have evolved to potentially
better interact with niche specific receptors. The fact that AgI/II
genes from more invasive streptococcal species cluster separately
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FIGURE 1 | Homology of AgI/II Family Proteins. (A) The evolutionary history was inferred by using the Maximum Likelihood method and JTT matrix-based model
(Jones et al., 1992) using full-length amino acid sequences of the indicated proteins. The tree with the highest log likelihood (–21701.96) is shown. The tree is drawn
to scale, with branch lengths measured in the number of substitutions per site. Evolutionary analyses were conducted in MEGA X (Kumar et al., 2018).
(B) Conservation of individual domains is shown (top) as the pairwise identity percentage resulting from a MUSCLE protein alignment of each individual domain, as
well as the primary structure and amino acid length of AgI/II proteins from select streptococci (bottom). The domains shown are the N-terminal region (N; blue),
alanine-rich repeats (A; purple), the variable region (V; green), proline-rich repeats (P; yellow), the C-terminal region (C; orange), and the cell wall anchoring region
(CWA; gray). The Uniprot IDs for protein sequences used in both (A,B) are as follows: S. mutans SpaP (P23504), S. gordonii SspA (Q54185), S. gordonii SspB
(Q54186), S. agalactiae BspA (Q8E589), S. agalactiae BspC (A0A380IJX7), S. pyogenes AspA (Q48S75), S. intermedius Pas (Q9KW51), S. sobrinus SpaA
(Q53414), S. sanguinis PAc (F3V086), S. criceti PAaA (Q9LBG3), S. downei PAh (Q59HN9), and S. suis SSP-5 (A0A0Z8CV71).
from the viridans streptococci supports this theory (Figure 1A).
One factor contributing to the distribution and clustering of
AgI/II genes is their ability to be shared via horizontal gene
transfer. An example of this is seen with the GAS and GBS
AgI/II genes. In GAS, the AgI/II genes are located on the
integrative and conjugative element named region of difference
2 (RD2), which is thought to be horizontally shared between
GBS, conferring pathogenic traits that support invasive disease
in pregnant women and neonates (Zhang et al., 2006; Sitkiewicz
et al., 2011; Chuzeville et al., 2015; Deng et al., 2019; Jain et al.,
2019). It is especially concerning that this virulence factor is
able to spread horizontally since this family of proteins has
a wide variety of pathogenic functions, and their presence in
streptococcal species occupying unique niches may correlate with
the ability to cause disease as well.
STRUCTURE
The primary structure of AgI/II proteins is shown in Figure 1B.
AgI/II proteins begin with an N-terminal domain containing
a signal peptide mediating secretion via the general secretory
pathway (Scott and Barnett, 2006). This is adjacent to the
A-domain, a region containing multiple alanine-rich repeats
(Kelly et al., 1989). The A-domain is connected to a globular
domain termed the V-domain based on the variability observed
in this region between strains (Brady et al., 1991). The V-domain
contains a putative binding pocket, which will be elaborated on
in greater detail further on. At the other end of the V-domain
is the P-domain, termed for the presence of proline-rich repeats
within this region (Kelly et al., 1995). Following the P-domain
is the C-terminal region, which consists of two or three globular
IgG-like domains. Finally, there is an LPXTG motif for sortase-
mediated cell wall anchoring (Kelly et al., 1989). Overall, the
AgI/II proteins adopt a cell wall-anchored stalk structure formed
by interactions between the intertwined A- and P-domains, which
lifts the globular V-domain over 50 nm away from the cell surface
in the case of the S. mutans SpaP (Larson et al., 2010). The A- and
P-domains of SpaP were shown to utilize a unique interlocking
between tyrosine residues from heptad repeat motifs in the
A-domain with hydrophobic pockets consisting of PxxP motifs
within the P-region (Larson et al., 2010). The A- and P-domains
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are significantly smaller in some homologs such as the Bsp
proteins of GBS (Figures 1B, 2), and it has also been shown that
the interaction between A- and P-domains within these homologs
is formed in a different manner. The A-domain of BspA contains
an asparagine seam whose hydrogens interact with oxygen and
nitrogen atoms within the P-domain (Rego et al., 2016). In
addition to the A- and P-domains interacting, the tertiary stalk
structure of AgI/II proteins is further stabilized by interactions
between the N- and C-terminal domains in SpaP (Heim et al.,
2014). As the structure of the N-terminal domain in other
homologous proteins has not been experimentally determined
thus far, the level of conservation of such a locking mechanism
remains to be seen.
In addition to projecting the V-domain away from the cell
surface to improve interactions with ligands, this stable stalk
structure allows for a degree of flexibility that is known to
promote bacterial attachment under shear conditions. While
this tertiary structure is highly conserved, there is regional
variability particular to individual species, especially at the
V-domain. Interestingly, the full-length protein sequences used
to generate the phylogenetic tree shown in Figure 1A cluster
into a group of viridans streptococci and a separate group
of more traditionally invasive species. Representatives of these
two AgI/II protein structures, SpaP from S. mutans and BspA
from GBS are shown in Figure 2. These two species were
chosen because each has the largest number of domains with
experimentally determined structures published within each
cluster. The structural differences between homologs contribute
to both overlapping and distinct functions for AgI/II proteins
within streptococci. For example, AgI/II proteins from some
species are able to bind to sialic acids, while those from
other species cannot (Demuth et al., 1990a,b; Soell et al.,
1994; Vernier et al., 1996; Chatenay-Rivauday et al., 1998).
Structural differences exist even within the phylogenetic clusters,
as seen by variations in the published V-domain structure
from S. gordonii SspB (Forsgren et al., 2009) from that of
SpaP. These types of species-dependent variations in AgI/II
function will be discussed in greater detail in the following
FIGURE 2 | Comparison of SpaP and BspA Protein Structures. (A) PyMOL was used to combine the published models for domains of SpaP (N-terminus
PDB:4TSH, A3VP1 PDB:3IOX, C-terminus PDB:6E3F) and BspA (V-domain, C-terminus PDB:5DZA). Additional SpaP A and P repeats were modeled from A3VP1,
as were the A- and P-domains for BspA. As there is no structure for the N-terminal domain of any AgI/II protein among the cluster of invasive species shown in
Figure 1A, the BspA N-terminus is depicted by an oval. Light blue indicates the N-terminal domain, purple indicates the A-domain, green indicates the V-domain,
yellow indicates the P-domain, and the shades of orange indicate different globular domains at the C-terminus. The V-domain of SpaP (B) and BspA (C) have been
enlarged with arrows pointing to binding pockets.
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sections. It is likely that some of these functional variations
also depend on structural differences in domains other than the
V-domain. While the full structure of SpaP has been mostly
solved (Heim et al., 2014, 2015), other than the C-domain of
S. pyogenes AspA (Hall et al., 2014) and GBS BspA V- and
C-domains (Rego et al., 2016), the structures of additional
AgI/II domains from the cluster of invasive streptococci have
not been experimentally determined. A better understanding
of the structural differences between these AgI/II orthologs
may reveal key insights regarding their unique mechanisms for
colonization or disease progression. Additionally, the structure
of Enterococcus faecalis Asc10 displays a primary structure akin
to that of AgI/II proteins (Waters et al., 2004; Chuang et al.,
2009). The region analogous to the AgI/II V-domain of Asc10
was recently shown to have a similar structure to the V-domain
of S. gordonii SspB (Schmitt et al., 2018). As such, gaining a better
understanding of the AgI/II structure may indirectly provide
information regarding the mechanisms for pathogenesis utilized




One well known function of AgI/II proteins is their direct
contribution to auto-aggregation of streptococci without
intermediate molecules (Demuth et al., 1990a; Jenkinson and
Demuth, 1997; Brady et al., 2010; Maddocks et al., 2011;
Chuzeville et al., 2017; Deng et al., 2019). In recent years, it has
also been shown that fragments of S. mutans SpaP interact with
each other to form functional amyloid fibers (Oli et al., 2012).
This discovery prompted investigations regarding the molecular
interactions contributing to this phenomenon. As mentioned
earlier, AgI/II proteins are known to fragment, releasing what
was previously known as antigen II. These released fragments
can interact with surface anchored AgI/II proteins, particularly
through the V-domain of the surface anchored protein with
either the V- or C-domains of the fragmented protein (Heim
et al., 2015; Rego et al., 2016; Tang et al., 2016; Rivière et al., 2020).
AgI/II fragments comprised of the C-domain are able to form
the functional amyloid fibers in vitro (Tang et al., 2016; Barran-
Berdon et al., 2020). Furthermore, AgI/II functional amyloids
contribute to stabilization of S. mutans biofilms (Oli et al., 2012;
Tang et al., 2016; Barran-Berdon et al., 2020). Together, this
information suggests a critical role of AgI/II protein interactions
for the stabilization of streptococcal communities, as well as in
the formation of a structural foundation in biofilms that may
be taken advantage of by other species. The direct role of AgI/II
proteins in polymicrobial biofilms at various tissues will be
discussed below.
Extracellular Matrix Interactions
In addition to auto-interactions, AgI/II proteins are able to
interact with a large number of host ligands. As a class
of multifunction adhesins, AgI/II proteins play a role in
streptococcal interactions with extracellular matrix (ECM), or
canonical ECM proteins outside of the context of ECM, as seen
with some components of the salivary pellicle. These interactions
potentially facilitate adherence to both mucosal surfaces such as
the lung or vaginal epithelium, as well as non-mucosal surfaces
such as endothelial cells or teeth. Thus far, interactions with
the fibrous components of the ECM has been a major focus of
research, especially collagen, fibrinogen, fibronectin, and laminin.
As collagen is a major component of dentin (Linde, 1989), there
has been a large interest in collagen-binding proteins and their
role in mediating streptococcal access and invasion into tooth
surfaces. It has been shown that S. gordonii SspA and SspB (Love
et al., 1997; Heddle et al., 2003), S. suis AgI/II (Chuzeville et al.,
2017), and S. mutans SpaP (Love et al., 1997; Sciotti et al., 1997;
Beg et al., 2002; Petersen et al., 2002; Sullan et al., 2015; Esberg
et al., 2017) interact with and promote adherence to surfaces
coated with type I collagen, while S. intermedius Pas does not
(Petersen et al., 2001, 2002). Some of these studies utilized human
collagen (Sciotti et al., 1997; Beg et al., 2002; Chuzeville et al.,
2017), while others used rat tail collagen (Love et al., 1997; Sullan
et al., 2015). This is significant because a study that used type
I collagen from both human and rat tail found that S. mutans
SpaP interacts with rat and not human collagen (Petersen et al.,
2002). Differences in experimental set up might explain these
contradictory results, but additional investigation is required to
definitively determine the role of an AgI/II – collagen interaction
within the setting of human disease.
Streptococcal binding of laminin may also play a role in
colonization or invasion of various tissues (Singh et al., 2012).
Studies have shown that in addition to S. intermedius Pas
(Petersen et al., 2001), S. mutans SpaP (Sciotti et al., 1997;
Busscher et al., 2007) also interacts with laminin. Another
study saw a minor decrease in the ability of a S. mutans SpaP
knockout to bind human laminin but as the difference was not
significant, the authors concluded that SpaP did not contribute to
laminin binding (Beg et al., 2002); thus, additional investigations
into the interactions of AgI/II proteins with laminin are still
needed. Certain streptococcal species are also major agents of
infective endocarditis (IE), and the ability to bind fibronectin and
fibrinogen in addition to collagen may contribute to development
of this disease (Baddour, 1994). S. mutans SpaP (Sciotti et al.,
1997; Beg et al., 2002; Petersen et al., 2002; Kelemen et al., 2004;
Sullan et al., 2015), S. intermedius Pas (Petersen et al., 2001, 2002),
and S. suis AgI/II (Chuzeville et al., 2017) have all been shown to
bind fibronectin. Additionally, S. mutans SpaP (Beg et al., 2002;
Kelemen et al., 2004), S. suis AgI/II (Chuzeville et al., 2017), and
GBS BspC (Chuzeville et al., 2015) have been shown to bind
fibrinogen. The role of AgI/II proteins in binding of other ECM
components such as elastin is still a significant knowledge gap
that warrants future investigation.
Additional Host Ligands
Direct AgI/II interactions with host cells are also well
documented. These proteins mediate attachment to epithelial
(Vernier et al., 1996; Sciotti et al., 1997; Chuzeville et al., 2017;
Chaffanel et al., 2018; Pidwill et al., 2018; Jain et al., 2019) and
endothelial (Vernier et al., 1996; Al-Okla et al., 1999; Deng et al.,
2019; Oho and Nagata, 2019) cells, in addition to monocytes
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and fibroblasts (Soell et al., 1994; Chatenay-Rivauday et al., 1998,
2000; Petersen et al., 2001; Hajishengallis et al., 2002; Engels-
Deutsch et al., 2003). The diversity of different cell types that
streptococci adhere to using AgI/II proteins highlights their
dynamic role as adhesins. One ligand for S. mutans SpaP that
was identified early on is the intermediate filament (IF) protein,
keratin (Sciotti et al., 1997). More recently, vimentin, a type III IF
protein, was also identified as the GBS BspC receptor mediating
adherence to human cerebral microvascular endothelial cells
(hCMECs) (Deng et al., 2019). Despite the ubiquitous nature
of IF proteins as structural components in all cell types, they
remain severely understudied as receptors for AgI/II proteins,
and future studies should investigate the role of potential IF-
AgI/II interactions in pathogenesis.
Salivary agglutinin (SAG) is perhaps the best documented
host receptor for AgI/II proteins and will be discussed in
a dedicated section below; however, these investigations have
revealed the lectin-like properties of AgI/II proteins. For example,
sialic acid (and to a lesser degree, fructose, and mannose)
binding by S. sanguinis SSP-5 competitively inhibits aggregation
and interaction with SAG (Demuth et al., 1990a). Conversely,
S. mutans SpaP interaction with SAG was inhibited by fucose and
lactose, but not by sialic acid (Demuth et al., 1990b). Interestingly,
S. mutans AgI/II was shown to bind N-acetylneuraminic acid (a
sialic acid) in addition to fucose on the surface of monocytes
and KB cells (Soell et al., 1994; Vernier et al., 1996; Chatenay-
Rivauday et al., 1998). Additionally, the V-domain of AgI/II
proteins is thought to contain a carbohydrate-binding pocket
(Troffer-Charlier et al., 2002; Forsgren et al., 2009; Rego et al.,
2016), and another cleft between two of the globular C-terminal
domains of SpaP was shown to bind glucose (Larson et al., 2011).
Collectively, this information indicates that while members of
the AgI/II family of proteins have similar and often overlapping
specificity for host factors, many of these interactions may be
unique to both the AgI/II protein expressed in certain species, as
well as the cell type in which the interaction is taking place.
AgI/II proteins are also able to interact with a number
of receptors involved in immune signaling. S. gordonii SspA
and SspB have been shown to interact with α5β1 integrins
on human lung epithelial A549 cells, HEp-2 cells, and coated
plates (Nobbs et al., 2007; Andrian et al., 2012). Furthermore,
the interaction between SspA/SspB with α5β1 integrins was
shown to be mediated via the N-terminal portion of the protein,
and this interaction contributed to invasion into HEp-2 cells
in addition to adherence (Nobbs et al., 2007). Due to the
widespread expression of α5β1 integrins in multiple cell types, it
is likely that their interaction with AgI/II proteins contributes to
adherence and invasion in other cell types as well, but this has yet
to be confirmed.
INTERACTIONS WITH THE IMMUNE
SYSTEM
Phagocytosis
AgI/II proteins are able to interact with or evade the host immune
system, further impacting disease. One main niche where this
occurs is within the bloodstream, as streptococci are often
associated with blood-borne systemic diseases. AgI/II proteins
have anti-phagocytic functions that may promote survival within
the host and development of high levels of bacteremia. An
S. suis AgI/II deficient mutant was more readily internalized
by resident peritoneal macrophages but had no difference
from wildtype in intracellular survival (Auger et al., 2019).
The knockout strain also displayed increased internalization
by dendritic cells, along with decreased intracellular survival
within the dendritic cells. Furthermore, the S. suis AgI/II
knockout was killed more readily when exposed to whole
murine blood, collectively resulting in a dramatic difference
in both rapid clearance of the knockout strain from murine
blood and mouse survival upon intraperitoneal or intravenous
infection (Auger et al., 2019). Similarly, deletion of AspA in
GAS led to increased killing by the human neutrophil (HL60)
and mouse macrophage (J774.2) cell lines, while expressing
AspA in L. lactis led to decreased killing by the same cell lines
(Franklin et al., 2013). Interestingly, heterologous expression of
S. gordonii SspB within L. lactis had no impact on phagocytosis,
indicating species specific differences in the sufficiency of AgI/II
proteins to impact phagocytosis. This is also supported by the
fact that the opposite trend was observed with S. mutans PAc,
where a PAc knockout and S. mutans clinical strains with less
AgI/II surface expression exhibited a decreased ability to be
phagocytosed by human polymorphonuclear leukocytes (Nakano
et al., 2006). Furthermore, the PAc deficient strain was not cleared
as efficiently as wildtype S. mutans after intravenous injection
within a rat model of bacteremia.
Immune Signaling
AgI/II proteins have also been shown to modulate immune
responses while in the bloodstream. In the same rat model
for bacteremia that was mentioned above, significantly higher
concentrations of serum sialic acid [a marker for systemic
inflammation (Rajendiran et al., 2014)] were observed after
injection with the PAc deficient mutant as compared to the
wildtype control (Nakano et al., 2006). In this case, presence of the
AgI/II protein appeared to dampen inflammation, although the
opposite was observed in other S. mutans studies. As mentioned
earlier, AgI/II proteins interact with THP-1 monocytes derived
from human peripheral blood. S. mutans SpaP was able
to induce release of the neutrophil chemoattractant IL-8 by
THP-1 cells (Engels-Deutsch et al., 2003). SpaP also induced
the pro-inflammatory cytokines TNFα and IL-1β from THP-
1 cells, which was partially mediated by CD14 and TLR4,
but not significantly by TLR2 (Hajishengallis et al., 2002).
S. mutans Sr was similarly shown to bind human monocytes
and induce the release of TNF, IL-1, and IL-6 (Soell et al.,
1994). These seemingly contradictory results indicate complex
interactions that strike a delicate balance with the host immune
system. The mechanistic details regarding the contribution of
S. mutans AgI/II to immune suppression or activation should be
investigated in greater detail.
Despite the controversy involved with SpaP, most other
AgI/II proteins appear to induce a pro-inflammatory response
by cells found within the blood. S. intermedius Pas has been
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shown to induce IL-8 from THP-1 cells (Petersen et al., 2001).
S. gordonii SspA and SspB both also induce TNF, IL-6, IL-
10, and IL-12 release by bone marrow derived dendritic cells
(Andrian et al., 2012). Intraperitoneal infection of mice with
a S. suis AgI/II mutant strain led to decreased levels of a
large number of pro-inflammatory mediators within the plasma,
including IL-6, IL-12p70, IFN-γ, CCL2, CCL3, CCL4, CXCL1,
and CXCL2 (Auger et al., 2019). Additionally, TLR2 and TLR4
were shown to contribute to MyD88 dependent induction of
TNF, IL-1β, IL-6, and CCL3 in dendritic cells (Auger et al.,
2019). TLR2 and TLR4 both interact with CD14 to sense
extracellular factors and begin signal transduction (Arroyo-
Espliguero et al., 2004). One study showed that THP-1 cells
treated with vitamin D3 (known to increase expression of
CD14) were not stimulated to a higher degree by S. mutans
SpaP and concluded that CD14 was not a receptor for the
protein (Chatenay-Rivauday et al., 1998); however, another
study soon after showed that monoclonal antibodies specific
to CD14 and TLR4 (but not TLR2), both decreased immune
activation by SpaP in THP-1 cells (Hajishengallis et al., 2002).
This indicates that SpaP does likely interact with CD14, but
requires the intracellular signaling domain of TLR4 to induce
the expected immune responses. Collectively, this information
suggests an overwhelmingly pro-inflammatory response to AgI/II
proteins by white blood cells. Still, as there is evidence
for immune suppressive or anti-phagocytic characteristics of
some of the AgI/II proteins, it remains possible that these
AgI/II proteins have similarly complex interactions with the
immune system under conditions or niches that have yet to
be investigated.
AgI/II proteins also promote inflammatory signaling in other
cell types, including epithelial and endothelial cells. As mentioned
previously, AgI/II proteins can bind α5β1 integrins, which are
known to sense the extracellular environment through adhesive
interactions and initiate signaling cascades that alter a variety
of host processes (Winograd-Katz et al., 2014). S. mutans
SpaP is able to bind to α5β1 integrins on human saphenous
vein endothelial cells (HSVECs) and osteoblasts, contributing
to inflammatory signaling (Al-Okla et al., 1999; Son et al.,
2012). AgI/II binding of α5β1 on the HSVEC surface was
shown to induce the MAPK signaling pathway and tyrosine
phosphorylation of phospholipase Cγ, focal adhesion kinase,
and paxillin (Al-Okla et al., 1999). This eventually leads to IL-
8 release in a PI3K independent manner. SpaP induction of
HSVEC IL-8 release was confirmed by another study as well,
along with release of IL-6 (Vernier et al., 1996). S. gordonii SspA
and SspB also increased IL-6, MCP-1 and IL-8 production in
A549 cells, and induction of both IL-6 and MCP-1 could be
inhibited with antibodies that blocked β1 integrin. Furthermore,
SspA and SspB induced IL-6 and IL-8 within HEp-2 cells, as
well as CXCL1 and CXCL2 in lung homogenates (Andrian et al.,
2012). Similarly, the GBS AgI/II protein known as BspC was
shown to induce inflammatory signaling in hCMECs leading to
meningitis-associated inflammation. BspC induced IL-8, IL-1β,
and CXCL1 release by hCMECs, and also KC protein and IL-
1β within a murine model of hematogenous meningitis (Deng
et al., 2019). This is a clear case where the AgI/II mediated
inflammatory signaling contributes to disease. Given the large
body of data showing that similar immune induction occurs at
other body sites, the direct role of AgI/II proteins in inflammatory
disease should be investigated in greater detail.
NICHE SPECIFIC INTERACTIONS
Oral Cavity
As mentioned previously, due to the initial discovery of AgI/II
proteins in S. mutans, the AgI/II proteins of streptococci that
colonize the oral cavity are the most well studied. Within the
oral cavity, AgI/II proteins are known to interact with one of
the host innate defense proteins known as salivary agglutinin
(SAG). Initial studies identified that S. mutans SpaP (Brady
et al., 1992; Hajishengallis et al., 1994; Sciotti et al., 1997; Ahn
et al., 2008), S. sanguinis PAc (Demuth et al., 1988, 1990a;
Lamont et al., 1991), S. sobrinus SpaA (Lamont et al., 1991),
and S. gordonii SspA (Jenkinson et al., 1993) all interacted with
fluid-phase SAG, resulting in aggregation. The aggregation acts
as a defense mechanism in this case as it promotes clearance of
bacteria through actions such as swallowing. It has since been
discovered that SAG and the lung scavenger receptor protein
known as glycoprotein-340 (gp340) [also known as Deleted
in Malignant Brain Tumors 1 or DMBT1 (Mollenhauer et al.,
1997)] are the same protein (Prakobphol et al., 2000). In the
context of mucosal colonization, the protein has historically been
referred to as either SAG or more recently gp340, so it will
be simply referred to as SAG/gp340 in this review. Within the
oral cavity, SAG/gp340 can exist in fluid phase as a salivary
component, or in an adsorbed phase that can mediate bacterial
attachment to the tooth surface, thereby contributing to dental
plaque biofilm formation (Madsen et al., 2010). Interestingly,
it seems that AgI/II proteins have varying interactions with
these two phases of SAG/gp340. S. gordonii SspA and SspB,
S. intermedius Pas and S. mutans SpaP all contributed to
aggregation by fluid-phase SAG/gp340 at comparable levels, but
only the AgI/II proteins of S. gordonii mediated higher affinity
binding to surface-bound SAG/gp340 (Loimaranta et al., 2005;
Maddocks et al., 2011). Likewise, while GAS AspA contributes
to attachment to immobilized SAG/gp340, it did not cause
aggregation by fluid-phase SAG/gp340 (Maddocks et al., 2011).
The AgI/II protein of S. suis has also been shown to interact with
both fluid-phase and immobilized SAG/gp340, contributing to
both aggregation and surface adherence, respectively (Chuzeville
et al., 2017). While GAS and S. suis are not common colonizers
of the oral cavity, the ability for their AgI/II proteins to
interact with SAG/gp340 highlights the conservation of this
particular function.
An early study using monoclonal blocking antibodies revealed
that binding to fluid-phase and surface-immobilized SAG/gp340
is mediated by different regions of the AgI/II protein (Brady
et al., 1992). This was the first indication that different portions
of SAG/gp340 are accessible to AgI/II binding in its two physical
states. Multiple studies have investigated this phenomenon in
more detail, specifically examining the scavenger-rich cysteine
repeat (SRCR) domain of SAG/gp340 that is targeted by
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AgI/II proteins (Bikker et al., 2002, 2004). It was shown that
immobilized SRCR underwent a conformational change in the
presence of calcium that allowed for AgI/II protein interaction
with nanomolar affinity, whereas AgI/II protein interacted with
fluid-phase SRCR with micromolar affinity (Purushotham and
Deivanayagam, 2014). Additionally, SAG/gp340 size variants
exist that have altered interactions with AgI/II proteins from
different species (Jonasson et al., 2007). Furthermore, alternate
AgI/II V-domain segments within a group of S. mutans
human isolates were shown to confer differential saliva- and
SAG/gp340-mediated adherence (Esberg et al., 2012, 2017).
Taken together, this information suggests a complex co-evolution
of AgI/II proteins and SAG/gp340. While fluid-phase SAG/gp340
normally functions as part of host innate immunity to cause
aggregation and clearance of oral streptococci, certain species
have evolved to interact with the alternative conformation of
immobilized SAG/gp340 on tooth surfaces to promote adherence
instead. This provides a mechanism by which both commensal
and cariogenic streptococci maintain colonization of the oral
cavity. The role of interactions between AgI/II proteins with
SAG/gp340 in other diseases will be discussed further on.
Streptococcal AgI/II proteins are able to interact with other
microbes known to colonize the oral cavity, contributing
to polymicrobial biofilm formation. Often, these interactions
stabilize the colonization of pathogens associated with the
development of periodontitis or dental caries. While SAG/gp340
has been shown to increase adherence of both S. mutans
and S. sobrinus to immobilized early plaque formers such
as S. sanguinis and Actinomyces viscosus, both species were
also shown to adhere to the plaque formers in an AgI/II
dependent manner, even without the addition of saliva or purified
SAG/gp340 (Lamont et al., 1991). S. gordonii SspA and SspB
have similarly been shown to interact with Actinomyces oris
(Back et al., 2015) and the periodontitis-associated pathogen
Porphyromonas gingivalis (Brooks et al., 1997; Daep et al.,
2006). In the case of P. gingivalis, it was determined that the
minor fimbrial antigen (Mfa1) of P. gingivalis interacts with
a specific sequence motif found in the C-terminal domain of
the SspA/B proteins which is not highly conserved in SpaP
(Demuth et al., 2001; Daep et al., 2006; Forsgren et al., 2010).
The crystal structure of SspB revealed that this region protrudes
from the protein, creating a handle for initial attachment of
P. gingivalis and inclusion into a biofilm (Forsgren et al.,
2010). Peptides mimicking this region have been shown to
block the SspB-Mfa1 interaction and inhibit P. gingivalis
virulence within a murine model for periodontitis (Daep et al.,
2011). Furthermore, small molecule inhibitors were recently
identified that similarly block the SspB-Mfa1 interaction and
attenuate the ability of P. gingivalis to cause periodontitis
in vivo (Roky et al., 2020). S. gordonii SspA and SspB,
S. intermedius Pas, and S. mutans SpaP have also all been
shown to contribute to aggregation with Actinomyces naeslundii,
another organism associated with periodontitis (Jakubovics et al.,
2005b). Additionally, S. mutans SpaP mediates interactions with
Fusobacterium nucleatum ssp. polymorphum, which in turn is
known to initiate adherence of other periodontal pathogens
(Guo et al., 2017).
AgI/II proteins also contribute to interactions with pathogens
associated with dental caries. For example, Lactobacillus casei
is frequently isolated from dental caries. Co-culturing L. casei
with S. mutans increases the ability of L. casei to form biofilms,
and this increase was shown to be SpaP dependent (Wen
et al., 2010, 2017). Additionally, the fungal pathogen Candida
albicans is commonly associated with oral streptococcal biofilms,
and its presence has recently been shown to be positively
correlated with cariogenic traits of S. mutans in caries-related
biofilms (Falsetta et al., 2014; Bachtiar and Bachtiar, 2018).
AgI/II proteins are known to interact with the Agglutinin-
like sequence family proteins Als1 and Als3 of C. albicans,
contributing to the formation of polymicrobial communities.
For example, S. gordonii SspB interactions with C. albicans Als3
have been shown to contribute to biofilm formation (Bamford
et al., 2009; Silverman et al., 2010). S. mutans SpaP was also
shown to be important for incorporation of C. albicans within
a two-species biofilm, as well as for acid production within the
biofilm, which may contribute to the progression of dental caries
(Yang et al., 2018).
Despite the body of work indicating the role of AgI/II proteins
in polymicrobial biofilm formation with oral pathogens, it has
been shown that S. mutans spaP is significantly downregulated
within two-species biofilms with S. sanguinis, S. oralis or L. casei
(Wen et al., 2010). Very little is known regarding the regulation
of AgI/II family proteins, but this indicates that at least within the
context of biofilm formation, the regulation of AgI/II proteins is
complex and warrants further investigation. Additionally, while it
is known that AgI/II proteins contribute to oral disease through
adherence or even invasion of dentinal tubules (Love et al., 1997),
the role of AgI/II proteins in the immune response within the oral
cavity remains largely unexplored.
Respiratory Tract
Streptococci are often colonizers of the nasopharyngeal tract and
are a common cause of lung infections. The role of AgI/II proteins
in streptococcal persistence within these two niches has been
characterized mainly with S. suis, S. gordonii, and GAS. There
is serotype-specific variation in the S. suis AgI/II contribution
to respiratory infection. The S. suis AgI/II protein contributes
to adherence to NPTr porcine tracheal cells in a serotype 9
strain, but not in a serotype 2 strain (Chuzeville et al., 2017).
A mutant lacking the AgI/II protein in the serotype 9 strain
also displayed decreased nasal cavity and tonsil bacterial burden
within a porcine model for respiratory infection (Chuzeville et al.,
2017). As S. suis is also able to cause human infections, it would
be of interest to examine this in models for human disease.
Studies with S. gordonii have used human cell-based models
for disease. Some of these were done using HEp-2 cells which
were initially thought to be derived from a human laryngeal
epithelial carcinoma, however, it has been shown that the cell
line was actually the result of HeLa cell contamination (Gartler,
1968). In order to provide historical context, these results will
still be mentioned. S. gordonii SspA and SspB contribute to
adherence and invasion of the HEp-2 cell line (Jakubovics et al.,
2005a; Nobbs et al., 2007; Andrian et al., 2012). As mentioned
earlier, this was shown to be mediated by recognition of β1
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integrin by SspA and SspB (Nobbs et al., 2007). SspA and
SspB contribute to S. gordonii adherence to a lung epithelial
cell line (A549) through β1 integrin as well (Andrian et al.,
2012). Additionally, AspA contributes to GAS colonization of
the nasopharynx, as seen by its role in adherence to Detroit
562 laryngeal epithelial cells (Franklin et al., 2013). An AspA
deficient mutant displayed decreased nasopharyngeal and lung
bacterial burden within a murine model of respiratory infection
(Franklin et al., 2013). While AspA has also been linked to
innate immunity through repression of phagocytic killing (as
discussed previously), continued investigation is required to
determine its role in immune modulation specifically within
the respiratory tract. Additionally, while β1 integrin was shown
to be a receptor for SspA and SspB in HEp-2 cells, host
respiratory epithelial cell receptors for AgI/II proteins have not
been thoroughly characterized; however, since SAG/gp340 is
known to be expressed in the lungs, this would be one logical
interaction to examine.
Female Reproductive Tract Interactions
Numerous streptococcal species are known to colonize the
female reproductive tract. As seen with GBS, this can result
in pregnancy-associated complications such as pre-term births.
AgI/II proteins are beginning to be implicated in streptococcal
colonization of these tissues as well. Recently, the role of the
GBS Bsp proteins in colonization of the female reproductive
tract has been described. Deletion of BspC from GBS strain 515
resulted in a modest decrease in adherence to vaginal epithelial
cell (VECs); however, pretreatment with Bsp antisera resulted in
a large decrease in adherence as compared to the preimmune
sera control treatment (Pidwill et al., 2018). Additionally,
heterologous expression of both BspA and BspC within
Lactococcus lactis was shown to confer increased adherence to a
VEC monolayer (Rego et al., 2016; Pidwill et al., 2018).
The GBS AgI/II proteins are also known to contribute to single
species biofilm formation (Chuzeville et al., 2015), but there is
evidence that these proteins mediate polymicrobial interactions
as well. As mentioned earlier, AgI/II proteins are able to interact
with the fungal pathogen C. albicans, which is also often co-
isolated with GBS from the vaginal tract (Monif and Carson,
1998; Bayó et al., 2002; Cools et al., 2016). BspA and BspC
were shown to mediate direct interaction between GBS and
C. albicans (Rego et al., 2016; Pidwill et al., 2018). Furthermore,
adherence of both GBS and L. lactis surrogate expression strains
to VECs in the presence of C. albicans was largely mediated
by expression of BspA and BspC. The association between GBS
and C. albicans is dependent on the Als3 protein of C. albicans
(Pidwill et al., 2018). Interestingly, Als3 is the same protein that
was discussed earlier as being the receptor for AgI/II proteins of
oral streptococci, indicating that these interactions are not niche
specific. These experiments were all conducted in vitro. As such,
the role of AgI/II interactions with C. albicans within the female
reproductive tract in vivo remains unexplored.
Other reports of AgI/II interactions within the female
reproductive tract are not as direct or as thoroughly studied
as the Bsp interaction with vaginal epithelium, as is seen with
GAS. Colonization of the genitourinary tract by GAS is a risk
factor for puerperal sepsis, and it is possible that the GAS AgI/II
protein contributes to colonization of this niche. GAS adherence
to vaginal epithelium and colonization of murine vaginal tract
was shown to be mediated by genes located on RD2 (Jain
et al., 2019). As mentioned earlier, GAS RD2 contains the AgI/II
protein AspA. The individual contribution of AspA to vaginal
colonization, however, has not yet been shown. Future studies
should additionally aim to determine what, if any, impact AgI/II
proteins have on streptococcal ascending infection or immune
modulation resulting in adverse pregnancy outcomes.
Meningitis
Several streptococcal species are able to penetrate the blood-
brain barrier (BBB) in order to cause meningitis, including
S. pneumoniae, S. suis and GBS (Doran et al., 2016). Only in GBS
has the role of AgI/II been investigated. A recent study revealed
that BspC promoted GBS adherence to hCMECs, a model of
the BBB, by interacting with the C-terminus of the intermediate
filament protein known as vimentin (Deng et al., 2019). BspC
itself induced meningitis-associated inflammation, as discussed
in the immune signaling section, and the BspC-vimentin
interaction was also necessary for disease progression. A BspC-
deficient mutant was unable to cause meningitis within a murine
model, while vimentin-deficient mice were protected from
infection by wildtype GBS. Furthermore, vimentin was shown to
localize to the cell surface in response to interaction with BspC,
although the mechanisms governing this reorganization are not
yet understood. While S. suis AgI/II contributions to systemic
infections (discussed within the “Interactions With the Immune
System” section) have been previously investigated, their role
specifically within central nervous system infections should be
examined in future studies.
Infective Endocarditis
Another major example of AgI/II proteins interacting with
host endothelial cells is during infective endocarditis (IE),
which is characterized by the formation of a bacteria-containing
vegetation on a heart valve (Ford and Douglas, 1997). Viridans
group streptococci are the second largest cause of IE (Rajani
and Klein, 2020) and as such, the role of AgI/II proteins in
promoting IE has been widely investigated. The characteristic
vegetation in IE is typically composed of fibronectin and
fibrinogen, bacteria, and aggregated platelets (Baddour, 1994;
Ford and Douglas, 1997). As mentioned previously, many
AgI/II proteins are known to interact with both fibrinogen
and fibronectin. In addition, S. mutans PAc binds platelets
and causes their aggregation (Matsumoto-Nakano et al., 2009).
S. gordonii SspA and SspB have also been shown to bind human
erythrocytes (Demuth et al., 1996) and contribute to platelet
aggregation, although they do not directly mediate platelet
adhesion (Kerrigan et al., 2007).
The role of AgI/II proteins in interacting with endothelial
cells is also relevant here, although many of these studies have
used cell lines originating from regions distal to the heart.
Interactions with brain endothelium were described in the
previous section, but SpaP has also been shown to contribute to
S. mutans adherence to the human saphenous vein endothelial
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cell (HSVEC) line (Vernier et al., 1996; Al-Okla et al., 1999).
One study used human aortic endothelial cells (HAECs) to
model S. mutans interactions during IE, and while they did
not directly investigate the role of AgI/II proteins, they instead
looked at expression of known AgI/II protein receptor DMBT1
(SAG/gp340) in response to infection (Oho and Nagata, 2019).
The study found that SAG/gp340 release was upregulated in
response to S. mutans infection, but this actually decreased
adherence and invasion of the HAECs as compared to a
SAG/gp340 knockdown cell line. In this case, it seems that the
host utilizes the protein in a similar manner to fluid-phase
SAG/gp340 to aggregate and promote clearance of S. mutans.
Interestingly, despite the role of AgI/II proteins in interacting
with platelets, erythrocytes, and endothelial cells, as well as
elevated levels of anti-PAc antibody titers in IE patients (Russell
et al., 1992), the only study examining AgI/II proteins in an
in vivo model of IE found no phenotype for an AgI/II-deficient
mutant (Ryd et al., 1996). The study found no statistically
significant difference in CFUs present in heart valve vegetations
between the mutant and wildtype S. mutans strains 1-hour post
inoculation, although there was a trend toward fewer CFU of
the mutant strain. While they observed no difference in bacterial
clearance from the blood, CFU counts were only examined for
1 hour post infection, which may have been too early in disease
progression. Nonetheless, at 48 hours post infection, they still
observed no difference between the wildtype and AgI/II-deficient
mutant in CFU counts recovered from heart valve vegetations.
Despite these results, due to the numerous differences between
AgI/II protein interactions from different species that have
been described thus far, revisiting an in vivo model for IE
to investigate the contribution of AgI/II proteins from other
species may provide novel insights into the development of
the disease. Additionally, it is also possible that AgI/II proteins
mediate IE disease through an altered immune response instead
of through direct adherence. A recent study showed that there is
a high level of peptide similarity between the S. mutans AgI/II
protein and cardiovascular autoantigens (Lucchese, 2017). The
role of the elevated anti-AgI/II antibody titers (Russell et al.,
1992) in recognizing these autoantigens to promote IE should
be investigated.
AGI/II PROTEINS AS THERAPEUTIC
TARGETS
Given the growing recognition of their role in promoting
streptococcal colonization and pathogenesis, the potential
for AgI/II proteins to serve as therapeutic targets warrants
consideration. Reflecting the timeline for discovery of this protein
family, such investigations to date have primarily focused on
exploiting the AgI/II protein of S. mutans to develop an anti-
caries vaccine. Since it was first shown that antibodies against
SpaP can impair adherence of S. mutans to SAG immobilized on
the tooth surface (Hajishengallis et al., 1992), numerous vaccine
strategies have been explored, with the ultimate goal of inducing
a mucosal immune response that inhibits S. mutans colonization
of the oral cavity. Approaches include immunization with
recombinant SpaP peptides or chimeric proteins incorporating
additional S. mutans antigens (Lehner et al., 1981; Katz et al.,
1993; Yu et al., 1997; Hajishengallis et al., 1998; Zhang et al.,
2002; Batista et al., 2017), attenuated Salmonella enterica serovar
Typhimurium expressing a SpaP epitope (Huang et al., 2001;
Jiang et al., 2017), or DNA vaccines (Guo et al., 2004; Jia et al.,
2004, 2020; Shi et al., 2012), alongside passive immunotherapy
studies using monoclonal antibodies (Lehner et al., 1985, 1992).
While most of these studies have been at the preclinical phase
using animal models, human studies involving topical application
to the tooth surface of anti-SpaP monoclonal antibodies were
shown to be effective in preventing colonization by exogenously
administered or indigenous S. mutans (Ma et al., 1989, 1998).
Protection was reported to last for up to 2 years (Ma and Lehner,
1990; Ma et al., 1990), although others failed to replicate such
long-term effects (Weintraub et al., 2005), and no follow-up trials
have been performed in recent years. Alongside the technical
difficulties of vaccine development, another challenge with an
anti-caries vaccine is that S. mutans is not the only cariogenic
bacterium within the oral microbiota, which raises the question
of the efficacy of targeting a single bacterium. However, this issue
is less of a concern for the development of a vaccine to combat,
for example, GBS disease. Sialylated capsular polysaccharide
(CPS) has been a major focus of GBS vaccine strategies to date
(Kobayashi et al., 2016). However, there are 10 distinct CPS
serotypes, as well as non-typeable strains, meaning that any such
vaccine design could face the challenge of potential serotype
replacement/switching across geographical sites and over time.
Vaccines comprising a combination of protein-based antigens
have potential to confer broad protection that is serotype-
independent, and these are currently under investigation. Based
on SpaP, the Bsp proteins or domains thereof might well be
anticipated to induce function-blocking antibodies, while their
unique structural features offer the potential for the identification
of epitopes that allow the selective targeting of GBS while not
impacting other streptococci within the resident microbiota at a
given ecological niche.
Alongside vaccination strategies, improved knowledge of
structure-function relationships across the AgI/II proteins offers
the potential for mimetics or small molecule inhibitors to
be developed as a therapeutic route. As mentioned, proof-of-
concept has been established with use of a peptide to block
the interaction of S. gordonii AgI/II with P. gingivalis Mfa1,
resulting in reduced alveolar bone resorption in a murine model
of periodontitis (Daep et al., 2011). More recently, this peptide
has been incorporated into polymeric nanoparticles to improve
peptide dosage and persistence within the oral cavity (Mahmoud
et al., 2018), while small molecule inhibitors of the AgI/II-
MfaI engagement have also been found to effectively reduce
P. gingivalis virulence (Roky et al., 2020). Protective effects have
also been shown for a peptide (p1025) that blocks S. mutans
AgI/II adhesion to SAG. In a human trial, topical application of
p1025 to the teeth over a 3-week period prevented recolonization
by S. mutans for up to 4 months but not by another member
of the resident oral microbiota, Actinomyces (Kelly et al., 1999).
With our growing understanding of the importance of the AgI/II
protein family amongst pathogenic streptococci, opportunities
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FIGURE 3 | Summary of Site-Specific AgI/II Interactions. (A) AgI/II proteins promote direct interactions with vaginal epithelial cells, and interact with Als3 protein of
C. albicans, promoting fungal and streptococcal adherence to the vaginal epithelium. (B) AgI/II proteins bind fluid-phase SAG/gp340, resulting in aggregation and
clearance through mechanisms such as swallowing, as well as to immobilized SAG/gp340 on the tooth pellicle, facilitating adherence and colonization. AgI/II
proteins mediate direct adherence to tooth components and invasion into dentinal tubules, resulting in caries formation, and also facilitate colonization and
polymicrobial biofilm formation with cariogenic pathogens, as well as with pathogens associated with periodontitis. (C) AgI/II proteins interact with vimentin on the
surface of brain endothelium, and also induce chemokine signaling and neutrophil chemotaxis characteristic of meningitis. (D) AgI/II proteins interact with β1 integrin
on the nasopharynx epithelium, resulting in adherence and invasion of the cells and consequently increased bacterial burden in the nasopharynx and lungs. (E) AgI/II
proteins promote aggregation of blood-borne bacteria, as well as attachment to and aggregation of platelets; however, there is currently insufficient evidence to
show this promotes increased vegetation formation on heart valves that is characteristic of infective endocarditis, as indicated by the question mark.
for development of therapeutic agents that target them should
remain an important area of investigation.
CONCLUSION AND FUTURE
DIRECTIONS
The AgI/II family of proteins display both overlapping and
diverse functions that vary between streptococcal species as well
as the niche within the host (Figure 3). The protein structure
itself has many unique features, with multiple intramolecular
interactions forming an elongated fibrillar stalk that projects the
V-domain containing a binding cleft away from the cell surface.
This cleft may be used to promote streptococcal colonization of
various tissues via both direct cellular adherence or interaction
with ECM components. Here we provide a historical perspective
of the existing literature and as such, the data presented represent
over 40 years of work. During this time, the field has progressed
significantly. Some of the pitfalls in the earlier studies that have
become clear in hindsight were discussed. In general, validated
cell lines, antibodies, recombinant proteins made with the benefit
of current structural knowledge, and other modern tools and
techniques could provide clarification or new insights into some
of the previously identified functions of AgI/II proteins. In
addition to the roles for AgI/II proteins in mucosal colonization
and blood-borne diseases that were discussed, there are also
functions that have yet to be investigated in detail. For example,
SspA and SspB protect S. gordonii from the antibiotic polymyxin
B, as well as the antibacterial peptides nisin and histatin-5
(Andrian et al., 2012). AgI/II proteins may also play a role in
streptococcal gut colonization, as the S. suis AgI/II was shown
to protect against acid stress (Chuzeville et al., 2017), and a
potential AgI/II protein identified in S. salivarius contributed
to adherence to intestinal epithelium (Chaffanel et al., 2018).
Each of these potential functions should be further investigated.
Additionally, future studies should aim to elucidate the potential
for post-translational modifications of AgI/II proteins such as
glycosylation to contribute to their functions. Understanding the
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diverse nature of these multifunctional adhesins will provide
novel insights into the mechanisms by which streptococci and
other organisms with structurally similar adhesins cause disease,
as well as provide targets for therapeutic intervention.
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